{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:33Z","timestamp":1774485513666,"version":"3.50.1"},"reference-count":66,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,7]]},"abstract":"<jats:p>The live-attenuated Japanese encephalitis virus (JEV) SA14-14-2 vaccine, produced in primary hamster kidney cells, is safe and effective. Past attempts to adapt this virus to replicate in cells that are more favorable for vaccine production resulted in mutations that significantly reduced immunogenicity. In this study, 10 genetically distinct Vero cell-adapted JEV SA14-14-2 variants were isolated and a recombinant wild-type JEV clone, modified to contain the JEV SA14-14-2 polyprotein amino acid sequence, was recovered in Vero cells. A single capsid protein mutation (S66L) was important for Vero cell-adaptation. Mutations were also identified that modulated virus sensitivity to type I interferon-stimulation in Vero cells. A subset of JEV SA14-14-2 variants and the recombinant clone were evaluated <jats:italic>in vivo<\/jats:italic> and exhibited levels of attenuation that varied significantly in suckling mice, but were avirulent and highly immunogenic in weanling mice and are promising candidates for the development of a second-generation, recombinant vaccine.<\/jats:p>","DOI":"10.4269\/ajtmh.14-0427","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T03:10:13Z","timestamp":1413256213000},"page":"98-107","source":"Crossref","is-referenced-by-count":18,"title":["Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice"],"prefix":"10.4269","volume":"92","author":[{"given":"Gregory D.","family":"Gromowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Yen","family":"Firestone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Bustos-Arriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen S.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Annu Rev Microbiol","first-page":"395","article-title":"The natural history of Japanese encephalitis virus","volume":"40","author":"Rosen","year":"1986"},{"key":"R2","series-title":"Am J Trop Med Hyg","first-page":"719","article-title":"Ecologic studies of Japanese encephalitis virus in Japan. IX. Epidemiologic correlations and conclusions","volume":"8","author":"Buescher","year":"1959"},{"key":"R3","series-title":"Annu Rev Entomol","first-page":"17","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"van den Hurk","year":"2009"},{"key":"R4","series-title":"Bull World Health Organ","first-page":"766","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011"},{"key":"R5","series-title":"Annu Rev Microbiol","first-page":"649","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990"},{"key":"R6","series-title":"Adv Virus Res","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003"},{"key":"R7","series-title":"Cell Host Microbe","first-page":"229","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008"},{"issue":"(Suppl 2)","key":"R8","series-title":"Vaccine","first-page":"26","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000"},{"key":"R9","series-title":"J Virol","first-page":"5446","article-title":"Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis","volume":"85","author":"Larena","year":"2011"},{"key":"R10","series-title":"J Interferon Cytokine Res","first-page":"521","article-title":"Mechanisms of evasion of the type I interferon antiviral response by flaviviruses","volume":"29","author":"Diamond","year":"2009"},{"key":"R11","series-title":"QJM","first-page":"219","article-title":"Encephalitis caused by flaviviruses","volume":"105","author":"Turtle","year":"2012"},{"key":"R12","series-title":"Nat Rev Microbiol","first-page":"115","article-title":"West Nile virus infection and immunity","volume":"11","author":"Suthar","year":"2013"},{"key":"R13","series-title":"Immunol Cell Biol","first-page":"196","article-title":"Evasion of innate and adaptive immunity by flaviviruses","volume":"81","author":"Diamond","year":"2003"},{"key":"R14","series-title":"Expert Opin Biol Ther","first-page":"95","article-title":"Current use and development of vaccines for Japanese encephalitis","volume":"8","author":"Beasley","year":"2008"},{"key":"R15","series-title":"Expert Rev Vaccines","first-page":"355","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011"},{"key":"R16","series-title":"Expert Opin Biol Ther","first-page":"1251","article-title":"Clinical development of IMOJEV (R)\u2013a recombinant Japanese encephalitis chimeric vaccine (JE-CV)","volume":"12","author":"Appaiahgari","year":"2012"},{"key":"R17","series-title":"N Engl J Med","first-page":"1465","article-title":"Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis","volume":"360","author":"Kumar","year":"2009"},{"key":"R18","series-title":"WHO Expert Committee on Biological Standardization","author":"WHO","year":"2014"},{"key":"R19","series-title":"Pediatr Infect Dis J","first-page":"643","article-title":"Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety","volume":"33","author":"Feroldi","year":"2014"},{"key":"R20","series-title":"Vaccine","first-page":"1638","article-title":"A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses","volume":"26","author":"Sohn","year":"2008"},{"key":"R21","series-title":"J Infect Dis","first-page":"221","article-title":"Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine\u2013a comparison of 1- and 3-month immunization schedules","volume":"177","author":"Tsai","year":"1998"},{"issue":"(Suppl 2)","key":"R22","series-title":"Vaccine","first-page":"1","article-title":"New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998","volume":"18","author":"Tsai","year":"2000"},{"key":"R23","series-title":"Lancet","first-page":"791","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001"},{"issue":"(Suppl 3)","key":"R24","series-title":"J Med Assoc Thai","first-page":"S195","article-title":"Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand","volume":"94","author":"Chotpitayasunondh","year":"2011"},{"key":"R25","series-title":"Vaccine","first-page":"5041","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007"},{"key":"R26","series-title":"Lancet","first-page":"1375","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunization in Nepalese children with Japanese encephalitis: a case-control study","volume":"366","author":"Ohrr","year":"2005"},{"key":"R27","series-title":"Vaccine","first-page":"3635","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010"},{"key":"R28","series-title":"Virus Genes","first-page":"95","article-title":"Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process","volume":"5","author":"Aihara","year":"1991"},{"key":"R29","series-title":"J Gen Virol","first-page":"409","article-title":"Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14","volume":"76","author":"Ni","year":"1995"},{"key":"R30","series-title":"Virology","first-page":"541","article-title":"Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2","volume":"177","author":"Nitayaphan","year":"1990"},{"key":"R31","series-title":"J Virol","first-page":"934","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001"},{"key":"R32","series-title":"J Gen Virol","first-page":"2209","article-title":"Characterization of the E-138 (Glu\/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone","volume":"86","author":"Zhao","year":"2005"},{"key":"R33","series-title":"Virology","first-page":"79","article-title":"Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro","volume":"223","author":"Chen","year":"1996"},{"key":"R34","series-title":"J Infect Dis","first-page":"1144","article-title":"Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA","volume":"171","author":"Sumiyoshi","year":"1995"},{"key":"R35","series-title":"Vaccine","first-page":"2675","article-title":"Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2","volume":"32","author":"Yang","year":"2014"},{"key":"R36","series-title":"Virology","first-page":"51","article-title":"JE Nakayama\/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease","volume":"366","author":"Chambers","year":"2007"},{"key":"R37","series-title":"J Gen Virol","first-page":"1959","article-title":"A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1\u2032 formation and contributes to attenuation","volume":"93","author":"Ye","year":"2012"},{"key":"R38","series-title":"Arch Virol","first-page":"1905","article-title":"Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions","volume":"157","author":"Sooryanarain","year":"2012"},{"key":"R39","series-title":"J Virol","first-page":"3503","article-title":"The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling","volume":"84","author":"Laurent-Rolle","year":"2010"},{"key":"R40","series-title":"Dev Biol Stand","first-page":"1","article-title":"Cells products safety. Background papers from the WHO Study Group on Biologicals. Geneva, 18\u201319 Nov. 1986","volume":"68","year":"1987"},{"key":"R41","series-title":"Expert Rev Vaccines","first-page":"607","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009"},{"key":"R42","series-title":"Dev Biol Stand","first-page":"159","article-title":"New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines","volume":"41","author":"van Wezel","year":"1978"},{"key":"R43","series-title":"Proc Soc Exp Biol Med","first-page":"670","article-title":"Biological characteristics and viral susceptibility of an African green monkey kidney cell line (Vero)","volume":"132","author":"Rhim","year":"1969"},{"key":"R44","series-title":"J Virol","first-page":"955","article-title":"Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero)","volume":"2","author":"Desmyter","year":"1968"},{"key":"R45","series-title":"Vaccine","first-page":"513","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988"},{"key":"R46","series-title":"J Virol","first-page":"3091","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003"},{"key":"R47","series-title":"Vaccine","first-page":"3010","article-title":"Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4","volume":"32","author":"Gromowski","year":"2014"},{"key":"R48","series-title":"J Microbiol","first-page":"698","article-title":"Biological and genetic properties of SA(1)(4)-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans","volume":"50","author":"Song","year":"2012"},{"key":"R49","series-title":"Am J Hyg","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938"},{"key":"R50","series-title":"Virology","first-page":"53","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006"},{"key":"R51","series-title":"Cell Host Microbe","first-page":"135","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007"},{"key":"R52","series-title":"Science","first-page":"558","article-title":"Interferon production and action in mouse, hamster and somatic hybrid mouse-hamster cells","volume":"160","author":"Carver","year":"1968"},{"key":"R53","series-title":"J Vet Sci","first-page":"111","article-title":"Isolation and genetic characterization of Japanese encephalitis virus from equines in India","volume":"13","author":"Gulati","year":"2012"},{"key":"R54","series-title":"J Virol","first-page":"13350","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005"},{"key":"R55","series-title":"J Virol","first-page":"9424","article-title":"Resistance to alpha\/beta interferon is a determinant of West Nile virus replication fitness and virulence","volume":"80","author":"Keller","year":"2006"},{"key":"R56","series-title":"J Virol","first-page":"2701","article-title":"Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004"},{"key":"R57","series-title":"J Gen Virol","first-page":"567","article-title":"Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus","volume":"84","author":"Lobigs","year":"2003"},{"key":"R58","series-title":"Vaccine","first-page":"258","article-title":"Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain","volume":"32","author":"Calvert","year":"2014"},{"key":"R59","series-title":"J Virol","first-page":"10347","article-title":"Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A","volume":"86","author":"Tu","year":"2012"},{"key":"R60","series-title":"Vaccine","first-page":"2746","article-title":"A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability","volume":"27","author":"Liang","year":"2009"},{"key":"R61","series-title":"Virus Res","first-page":"49","article-title":"Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42","volume":"137","author":"Lin","year":"2008"},{"key":"R62","series-title":"J Virol","first-page":"1934","article-title":"Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins","volume":"79","author":"Liu","year":"2005"},{"key":"R63","series-title":"J Gen Virol","first-page":"1505","article-title":"Comparison of nucleotide and deduced amino acid sequence of the 5\u2032 non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives","volume":"75","author":"Ni","year":"1994"},{"key":"R64","series-title":"DNA Seq","first-page":"437","article-title":"Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to vero cells","volume":"12","author":"Hong","year":"2001"},{"key":"R65","series-title":"Drugs","first-page":"115","article-title":"Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO]","volume":"69","author":"Duggan","year":"2009"},{"key":"R66","series-title":"Vaccine","first-page":"761","article-title":"Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses","volume":"11","author":"Wills","year":"1993"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/92\/1\/article-p98.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/92\/1\/article-p98.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/92\/1\/article-p98.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:31:20Z","timestamp":1723059080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/92\/1\/article-p98.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":66,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.14-0427","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}